The Diagnostic Biomarkers and Technology Branch (DBTB) stimulates and supports research to develop new biomarkers, diagnostic strategies, modeling, innovative technologies and improved devices that will lead to better tools for research and that can assist clinical decision-making.
Stimulate and support research that incorporates new knowledge from cancer biology and tumor-host interactions into cancer diagnosis research.
Stimulate and support research focused on the development of innovative technologies and devices for use in cancer diagnostics, prognostics and prediction.
Stimulate and support research to integrate and apply results from biomarker research and technology development into novel platforms for cancer diagnosis.
Stimulate and support research focused on the development and implementation of algorithms for analysis of high dimensional data applied to cancer diagnostics, prognostics and prediction
For more information on cancer marker development supported by DBT, please visit Marker Discovery.
For more information on the types of technologies supported by DBT, please visit Technology Development
For information on special funding initiatives and opportunities please visit Obtaining Support for Marker Discovery and Technology Development Projects and Technology Development Initiatives.
For a list of NCI/NIH resources and information of interest to technology developers see Resources and Additional Information for Technology Developers.
If you are a Small Business investigator seeking support for a project, please visit Small Business Funding Opportunities.
|James Tricoli, Ph.D.||Branch Chiefemail@example.com||(240) 276-5725|
|Brian Sorg, Ph.D.||Program Directorfirstname.lastname@example.org||(240) 276-5712|
|Miquel R. Ossandon, M.S.||Program Directoremail@example.com||(240) 276-5714|
|Tawnya McKee, Ph.D.||Program Directorfirstname.lastname@example.org||(240) 276-5719|
|Mary Mengesha||Administrative Supportemail@example.com||(240) 276-5723|